Mutational screening of newly diagnosed multiple myeloma patients by deep targeted sequencing

Haematologica. 2018 Nov;103(11):e544-e548. doi: 10.3324/haematol.2018.188839. Epub 2018 Jun 28.
No abstract available

Publication types

  • Clinical Trial, Phase II
  • Letter
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • DNA Mutational Analysis
  • Databases, Nucleic Acid*
  • Disease-Free Survival
  • Female
  • High-Throughput Nucleotide Sequencing
  • Humans
  • Male
  • Multiple Myeloma / genetics*
  • Multiple Myeloma / mortality*
  • Multiple Myeloma / pathology
  • Neoplasm Proteins / genetics*
  • Survival Rate

Substances

  • Neoplasm Proteins